State Street
CNTB

State Street’s Connect Biopharma Holdings CNTB Stock Holding History

State Street’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Buy
+66,700
New +$162K ﹤0.01% 3884
2021
Q4 		– Sell
-17,527
Closed -$420K – 4801
2021
Q3 		$420K Buy
+17,527
New +$397K ﹤0.01% 4047

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

State Street's CNTB Position: Q2 2026 in Review

State Street opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 66,700 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #3884 among its holdings. This is a return to the name: State Street previously reported a position in CNTB as recently as Q3 2021.

State Street first reported a position in CNTB in Q3 2021 and has held it in 2 quarters since. The position peaked at $420K in Q3 2021. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • State Street held 66,700 shares of Connect Biopharma Holdings worth $159K as of Q2 2026.
  • Connect Biopharma Holdings was a new State Street position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3884 holding.
  • State Street first reported a position in Connect Biopharma Holdings in Q3 2021 and has held it in 2 quarters since.
  • State Street's Connect Biopharma Holdings position peaked at $420K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.